<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="result" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="means" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="contrast" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">Addiction represents an enormous challenge to society .</segment>
<segment id="2" parent="1003" relname="attribution">Worldwide , it has been estimated</segment>
<segment id="3" parent="1003" relname="span">that alcohol , tobacco , and illicit drugs were responsible for more than 10 million deaths ,</segment>
<segment id="4" parent="1004" relname="span">with a higher impact in developed countries</segment>
<segment id="5" parent="4" relname="elaboration">where substance use disorders have been identified as responsible for life expectancy reversals .</segment>
<segment id="6" parent="1007" relname="concession">Societal and medical responses to the problem are far from optimal ,</segment>
<segment id="7" parent="1007" relname="span">but the appearance of new technologies offers room for improvement ,</segment>
<segment id="8" parent="1008" relname="span">with lots of new initiatives</segment>
<segment id="9" parent="8" relname="elaboration">launched and developed .</segment>
<segment id="10" parent="1012" relname="attribution">This special issue is intended to describe and discuss</segment>
<segment id="11" parent="1013" relname="span">how these new tools are helping to improve the assessment and treatment of such old problems</segment>
<segment id="12" parent="11" relname="elaboration">( addictive disorders ) ,</segment>
<segment id="13" parent="1014" relname="span">covering a wide diversity of novelties</segment>
<segment id="14" parent="13" relname="elaboration">that are being applied in the field .</segment>
<segment id="15" parent="1016" relname="span">Digital health entails the possibility</segment>
<segment id="16" parent="15" relname="purpose">to overcome existent problems around addictive disorders like stigmatization , addiction identification , treatment access , adherence and treatment efficacy</segment>
<segment id="17" parent="1016" relname="means">by facilitating the improvement in knowledge , assessment , diagnosis , and treatment of addictive disorders .</segment>
<segment id="18" parent="1018" relname="span">Assessment is one of the areas</segment>
<segment id="19" parent="18" relname="elaboration">where new solutions have probably reached furthest .</segment>
<segment id="20" parent="1021" relname="attribution">Think , for example , about transdermal sensors and ecological momentary assessment :</segment>
<segment id="21" parent="1021" relname="span">a clear example</segment>
<segment id="22" parent="21" relname="elaboration">of how new technologies can reach the core of a patient ’s drinking pattern .</segment>
<segment id="23" parent="1022" relname="joint">In this special issue , Barrio et al. investigate patients ’ attitudes towards transdermal sensors in real clinical settings .</segment>
<segment id="24" parent="1025" relname="span">Digital technologies might be useful</segment>
<segment id="25" parent="24" relname="purpose">to assess brain damage ,</segment>
<segment id="26" parent="1026" relname="span">and they bring us closer to understanding the mechanism(s)</segment>
<segment id="27" parent="26" relname="elaboration">underlying addiction .</segment>
<segment id="28" parent="1028" relname="span">Herreros et al. present a visuomotor rotation task</segment>
<segment id="29" parent="1029" relname="span">which might be the first step</segment>
<segment id="30" parent="1030" relname="span">towards developing a useful tool for the detection of cerebellum dysfunction</segment>
<segment id="31" parent="30" relname="means">by assessing alterations in implicit learning among chronic cannabis users .</segment>
<segment id="32" parent="1033" relname="span">New technologies have opened up the possibility</segment>
<segment id="33" parent="32" relname="elaboration">of not only assessing patients “ right here right now ”</segment>
<segment id="34" parent="1034" relname="contrast">but also of creating new realities ,</segment>
<segment id="35" parent="1034" relname="contrast">or should we better say virtual realities ?</segment>
<segment id="36" parent="37" relname="attribution">Ghiţă et al. show us</segment>
<segment id="37" parent="1037" relname="span">that virtual reality can enhance the assessment of alcohol-induced craving and anxiety .</segment>
<segment id="38" parent="1038" relname="span">Technological advances in neuroimaging and genetics have allowed deepening in the understanding of some learning processes</segment>
<segment id="39" parent="38" relname="elaboration">involved in substance use disorders .</segment>
<segment id="40" parent="1022" relname="joint">Garbusow et al. provide knowledge on how important processes , such as instrumental responses to relevant stimuli , are influenced by drinking patterns .</segment>
<segment id="41" parent="1042" relname="span">In this same line , Heinz et al. conduct a review</segment>
<segment id="42" parent="41" relname="elaboration">that starts with how Pavlovian and instrumental learning mechanisms interact in drug addiction</segment>
<segment id="43" parent="1041" relname="same_unit">and finishes with how these learning mechanisms and their respective neurobiological correlates can contribute to losing versus regaining control over drug intake .</segment>
<segment id="44" parent="1022" relname="joint">Paradoxically enough , new technologies do also have their own risks .</segment>
<segment id="45" parent="1022" relname="joint">Take , for example , internet gaming disorder .</segment>
<segment id="46" parent="1022" relname="joint">Ryu et al. present the development of a new assessment instrument for internet addiction , the Diagnostic Interview for Internet Addiction .</segment>
<segment id="47" parent="1022" relname="joint">And keeping in mind</segment>
<segment id="48" parent="1022" relname="joint">that new psychometric instruments are also new solutions to old problems ,</segment>
<segment id="49" parent="1049" relname="span">Chen et al. investigate an interesting phenomenon in addiction :</segment>
<segment id="50" parent="49" relname="elaboration">the intensity of memory addiction .</segment>
<segment id="51" parent="1022" relname="joint">They present us the development of the Addiction Memory Intensity Scale .</segment>
<segment id="52" parent="1052" relname="span">In the treatment area , this special issue offers an interesting combination of modalities :</segment>
<segment id="53" parent="1054" relname="span">newly designed pharmaceutical compounds</segment>
<segment id="54" parent="53" relname="elaboration">( nalmefene ) ,</segment>
<segment id="55" parent="1056" relname="span">naturally occurring psychoactive substances</segment>
<segment id="56" parent="55" relname="elaboration">( cannabidiol ) ,</segment>
<segment id="57" parent="1057" relname="span">and non-pharmacological , biological therapies</segment>
<segment id="58" parent="57" relname="restatement">( rTMS ) .</segment>
<segment id="59" parent="1060" relname="span">Barrio et al. report the main effectiveness analysis of a phase-IV study</segment>
<segment id="60" parent="59" relname="elaboration">conducted among alcohol dependent outpatients</segment>
<segment id="61" parent="1060" relname="elaboration">taking nalmefene , the only approved medication for alcohol reduction aims .</segment>
<segment id="62" parent="1061" relname="joint">The use of rTMS is presented by Cardullo et al. in a sample of cocaine and gambling patients .</segment>
<segment id="63" parent="1062" relname="joint">The stimulation of the left dorsolateral prefrontal cortex yields promising results .</segment>
<segment id="64" parent="1064" relname="span">Finally , Batalla et al. review the potential use of cannabidiol in addictive and comorbid psychotic disorders ,</segment>
<segment id="65" parent="64" relname="elaboration">pointing to a prominent role in the treatment of cannabis addiction .</segment>
<segment id="66" parent="1066" relname="span">Scientific advances and new technologies are providing new tools</segment>
<segment id="67" parent="66" relname="elaboration">that let us expand our knowledge ,</segment>
<segment id="68" parent="1067" relname="span">and improve diagnosis and treatment of addictive behaviors ,</segment>
<segment id="69" parent="1068" relname="joint">presenting us with opportunity for success</segment>
<segment id="70" parent="1068" relname="joint">and giving people back their health .</segment>
<group id="1000" type="span" />
<group id="1001" type="multinuc" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1001" relname="joint"/>
<group id="1003" type="span" parent="1002" relname="span"/>
<group id="1004" type="span" parent="3" relname="result"/>
<group id="1006" type="span" parent="1001" relname="joint"/>
<group id="1007" type="span" parent="1006" relname="span"/>
<group id="1008" type="span" parent="7" relname="elaboration"/>
<group id="1011" type="span" parent="1001" relname="joint"/>
<group id="1012" type="multinuc" parent="1011" relname="span"/>
<group id="1013" type="span" parent="1012" relname="same_unit"/>
<group id="1014" type="span" parent="1012" relname="same_unit"/>
<group id="1015" type="span" parent="1001" relname="joint"/>
<group id="1016" type="span" parent="1015" relname="span"/>
<group id="1018" type="span" parent="1001" relname="joint"/>
<group id="1019" type="multinuc" parent="1001" relname="joint"/>
<group id="1020" type="span" parent="1019" relname="sequence"/>
<group id="1021" type="span" parent="1020" relname="span"/>
<group id="1022" type="multinuc" parent="1019" relname="sequence"/>
<group id="1025" type="span" parent="1022" relname="joint"/>
<group id="1026" type="span" parent="1022" relname="joint"/>
<group id="1028" type="span" parent="1022" relname="joint"/>
<group id="1029" type="span" parent="28" relname="elaboration"/>
<group id="1030" type="span" parent="29" relname="elaboration"/>
<group id="1033" type="span" parent="1022" relname="joint"/>
<group id="1034" type="multinuc" parent="1022" relname="joint"/>
<group id="1036" type="span" parent="1022" relname="joint"/>
<group id="1037" type="span" parent="1036" relname="span"/>
<group id="1038" type="span" parent="1037" relname="elaboration"/>
<group id="1041" type="multinuc" parent="1022" relname="joint"/>
<group id="1042" type="span" parent="1041" relname="same_unit"/>
<group id="1049" type="span" parent="1022" relname="joint"/>
<group id="1052" type="span" parent="1022" relname="joint"/>
<group id="1053" type="multinuc" parent="52" relname="elaboration"/>
<group id="1054" type="span" parent="1053" relname="same_unit"/>
<group id="1055" type="multinuc" parent="1053" relname="same_unit"/>
<group id="1056" type="span" parent="1055" relname="same_unit"/>
<group id="1057" type="span" parent="1055" relname="same_unit"/>
<group id="1058" type="span" parent="1022" relname="joint"/>
<group id="1059" type="span" parent="1058" relname="span"/>
<group id="1060" type="span" parent="1059" relname="span"/>
<group id="1061" type="multinuc" parent="1059" relname="elaboration"/>
<group id="1062" type="multinuc" parent="1061" relname="joint"/>
<group id="1063" type="multinuc" parent="1062" relname="joint"/>
<group id="1064" type="span" parent="1063" relname="joint"/>
<group id="1065" type="multinuc" parent="1063" relname="joint"/>
<group id="1066" type="span" parent="1065" relname="joint"/>
<group id="1067" type="span" parent="1065" relname="joint"/>
<group id="1068" type="multinuc" parent="68" relname="elaboration"/>
	</body>
</rst>
